Impact of antimüllerian hormone assays on the outcomes of in vitro fertilization: A prospective controlled study

Fertility and Sterility

Volumn 101, Issue 1, 2014, Pages 134-137

  Aboulghar, Mohamed ^a,b   Saber, Walid ^a,b   Amin, Yahia ^b   Aboulghar, Mona M ^a,b   Serour, Gamal ^b,c   Mansour, Ragaa ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b The Egyptian IVF Center   (Egypt)

^c AL AZHAR UNIVERSITY   (Egypt)

Author keywords

AMH; cancellation rate; IVF; poor responder

Indexed keywords

GONADORELIN AGONIST; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; EGYPT; FEMALE; FERTILIZATION IN VITRO; HIGH RISK PATIENT; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PREGNANCY RATE; PRIORITY JOURNAL; STIMULATION;

EID: 84891559134     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.09.028     Document Type: Article

References (21)

1. R.L. Cate, R.J. Mattaliano, C. Hession, R. Tizard, N.M. Farber, and A. Cheung et al. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells Cell 45 1986 685 698 (Pubitemid 16063132)
2. C. Weenen, J.S. Laven, A.R. von Bergh, M. Cranfield, N.P. Groome, and J.A. Visser et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment Mol Humanit Rep 10 2004 77 83 (Pubitemid 38196508)
3. I.A. Van Rooij, F.J. Broekmans, E.R. te Velde, B.C. Fauser, L.F. Bancsi, and F.H. Jong et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve Hum Reprod 17 2002 3065 3071 (Pubitemid 35469254)
4. A. La Marca, S. Giulini, A. Tirelli, E. Bertucci, T. Marsella, and S. Xella et al. Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology Hum Reprod 22 2007 766 771
5. A. La Marca, S.M. Nelson, G. Sighinolfi, M. Manno, E. Baraldi, and L. Roli et al. Anti-Mullerian hormone (AMH) based prediction model for the live birth in assisted reproductive technology (ART) Reprod Biomed Online 22 2010 341 349
6. E. Anchaert, J. Smitz, J. Schiettecatte, B.M. Klein, and J.C. Arce The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin dose adjustments Hum Reprod 27 2012 1829 1839
7. S.M. Nelson, R.A. Anderson, F.J. Broekmans, N. Raine-Fenning, R. Fleming, and A. La Marca Anti-Müllerian hormone: clairvoyance or crystal clear? Hum Reprod 27 2012 631 636
8. M.A. Aboulghar, R.T. Mansour, G.I. Serour, and Y.M. Amin The prognostic value of successful in vitro fertilization in subsequent trials Hum Reprod 9 1994 1932 1934 (Pubitemid 24322397)
9. Z. Pandian, A.R. McTavish, L. Aucott, M.P. Hamilton, and S. Bhattacharya Intervention for poor responders to controlled ovarian hyperstimulation (COH) in in vitro fertilization (IVF) Cochrane Detabase Syst Rev 2010 CD004379
10. R. Fleming, F. Broekmans, C. Calhaz-Jorge, L. Dracea, H. Alexander, and A. Nyboe Andersen et al. Can anti-Mullerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation? Reprod Biomed Online 26 2013 431 439
11. A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, and A. Carducci et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) Hum Reprod Update 16 2010 113 130
12. S.K. Sunkara, V. Rittenber, N. Raine-Fenning, S. Bhattacharya, J. Zamora, and A. Coomarasamy Association between the number of eggs and live birth in IVF treatment: an analysis of 400135 treatment cycles Hum Reprod 26 2011 1768 1774
13. A.P. Yates, O. Rustamov, S.A. Roberts, H.Y.N. Lim, P.W. Pemberton, and A. Smith et al. Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF Hum Reprod 26 2011 2353 2362
14. A. Weghofer, W. Dietrich, D.H. Barad, and N. Gleicher Live birth chances in women with extremely low-serum anti-Mullerian hormone levels Hum Reprod 26 2011 1905 1909
15. F. Lamazou, V. Genro, F. Fuchs, M. Grynberg, V. Gallot, and N. Achour-Frydman et al. L'AMH seique n'a pas de valeur predictive en fecundation in-vitro en cycle natural modifie: analyse de 342 cycles The AMH assay is not of predictive value in modified natural cycle IVF: analysis of 342 cycles [in French] J Gynecol Obstet Biol Reprod 40 2011 205 210
16. J.S. Loh, and A. Maheshwari Anti-Mullerian hormone - is it a crystal ball for predicting ovarian ageing? Hum Reprod 26 2011 2925 2932
17. S.M. Nelson, and A. La Marca The journey from the old to the new AMH assay: how to avoid getting lost in the values Reprod Biomed Online 23 2011 411 420
18. O. Rustamov, A. Smith, S.A. Roberts, A.P. Yates, C. Fitzgerald, and M. Krishnan et al. Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability Hum Reprod 27 2012 3085 3091
19. T. Brodin, N. Hadziosmanovic, L. Berglind, M. Olovsson, and J. Holte Antimullerian hormone levels are strongly associated with live-birth rates after assisted reproduction J Clin Endocrinol Metab 98 2013 107 114
20. H. Lashen, W. Ledger, A. Lopez-Bernal, and D. Barlow Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile? Hum Reprod 14 1999 964 969 (Pubitemid 29176475)
21. U. Ulu, I. Ben-Shlomo, E. Turan, H.F. Erden, M.A. Akman, and M. Bahceci Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles Reprod Biomed Online 6 2003 439 443 (Pubitemid 36849804)